We isolated a full-length human GAP1 m cDNA that contained an open reading frame encoding a protein of 849 amino acids and a predicted molecular mass of 96.5 kDa. The protein sequence is identical to that of the previously cloned human GAP1 m [2] with two exceptions: Ala216 is replaced by a threonine and Ser646 is absent from our sequence. There is 53.7% identity between GAP1 IP4BP and GAP1 m at the protein sequence level and both contain similar structural features, namely a highly conserved GTPase-activating domain, C2A and C2B domainswhich, by analogy to synaptotagmin II, may serve as Ca 2+ -dependent and Ca 2+ -independent phospholipid-binding motifs, respectively -and a single pleckstrin homology (PH) domain that includes a Bruton's tyrosine kinase (Btk) motif (Figure 1a ) [3] . Although the important structural units and the carboxy-terminal tail show some sequence divergence between GAP1 IP4BP and GAP1 m , a major structural difference -at least at the level of the primary sequence -is the alanine-rich 26 residue extension at the amino terminus of GAP1 m (for an alignment of these two proteins and details of the GAP1 family see [4] ).
Results and discussion
We isolated a full-length human GAP1 m cDNA that contained an open reading frame encoding a protein of 849 amino acids and a predicted molecular mass of 96.5 kDa. The protein sequence is identical to that of the previously cloned human GAP1 m [2] with two exceptions: Ala216 is replaced by a threonine and Ser646 is absent from our sequence. There is 53.7% identity between GAP1 IP4BP and GAP1 m at the protein sequence level and both contain similar structural features, namely a highly conserved GTPase-activating domain, C2A and C2B domainswhich, by analogy to synaptotagmin II, may serve as Ca 2+ -dependent and Ca 2+ -independent phospholipid-binding motifs, respectively -and a single pleckstrin homology (PH) domain that includes a Bruton's tyrosine kinase (Btk) motif ( Figure 1a ) [3] . Although the important structural units and the carboxy-terminal tail show some sequence divergence between GAP1 IP4BP and GAP1 m , a major structural difference -at least at the level of the primary sequence -is the alanine-rich 26 residue extension at the amino terminus of GAP1 m (for an alignment of these two proteins and details of the GAP1 family see [4] ).
PH domains are important structural features of many signalling proteins that require either a direct plasma membrane localisation or recruitment from the cytosol to the membrane for their functional association with specific targets [5] . Some PH domains have recently been shown to bind specifically to phosphoinositides and disruption of binding leads to loss of function; for example, Btk binds to both phosphoinositides [6] and IP 4 [7] through this domain, as determined by mutagenesis.
Initially, we cloned the full-length GAP1 m cDNA into the pGEX4T-2 expression vector but were unable, under the conditions described in the Materials and methods, to isolate sufficient protein for binding analysis; however, a deletion mutant in which the C2A and C2B domains were removed (∆C2GAP1 m ) was found to be more soluble and allowed easy purification of the resultant fusion protein. As shown in Figure 1b, Expression of GAP1 IP4BP and GAP1 m constructs was checked by transiently transfecting COS-7 cells followed by immunoblotting with specific anti-peptide antibodies. Western blotting of a whole cell lysate 48 hours after transfection showed the presence of proteins of the predicted molecular weight and, furthermore, confirmed that there was no cross-reactivity between the anti-GAP1 IP4BP and anti-GAP1 m antibodies (data not shown). Expression and immunocytochemical analyses of GAP1 IP4BP in either COS-7 or HeLa cells -both of which contain endogenous GAP1 IP4BP and GAP1 m as determined by reverse transcription (RT)-PCR analysis -demonstrated a discrete plasma membrane localisation (Figure 2a ), which was confirmed independently by analysis of the expression of a green fluorescent protein -GAP1 IP4BP fusion protein (GFP-GAP1 IP4BP ) in live cells (data not shown). In contrast, immunocytochemical analysis of COS-7 cells expressing GAP1 m showed a predominantly perinuclear localisation of the protein, in addition to a small cytoplasmic pool ( Figure 2b ). The cytoplasmic localisation may be an artefact of overexpression, although it is entirely consistent with the original purification of GAP1 m from both particulate and cytoplasmic fractions [9] . The subcellular localisation of GAP1 m was confirmed using GFP-GAP1 m (data not shown). Furthermore, in both COS-7 and HeLa cells, the discrete subcellular distribution of the two GAPs was observed even upon coexpression of both GAPs (Figure 2c ).
To understand the mechanism underlying this difference in subcellular localisation, we initially constructed a GFP-GAP1 IP4BP deletion mutant in which both the C2A and C2B domains were removed (GFP-∆C2GAP1 IP4BP ). As can been seen in Figure 3a , this deletion had no effect on the plasma membrane localisation of GAP1 IP4BP . Specific point mutations within the PH domain of full-length GAP1 IP4BP (Lys599→Gln, Lys600→Gln, Arg601→Gln), however, had the dual effect of completely abolishing IP 4 binding (J.R.B. and P.J.C., unpublished observations) resulting in a complete loss of plasma membrane localisation (Figure 3b ). This suggests that the PH domain of GAP1 IP4BP constitutes both an IP 4 -binding and a phospholipid-binding site and that, functionally, the two binding sites may overlap. This has an [11] . Thus, the possibility exists that IP 4 may function to regulate such an event through its ability to bind at the ER, where an isoform of the Ins(1,4,5)P 3 3′-kinase also resides [12] . One question raised by this particular localisation concerns the small GTP-binding protein that is the physiological substrate for GAP1 m : GAP1 m has been biochemically characterised as a GAP for Ras in vitro [13] , but its perinuclear localisation would suggest that it may not interact with the active plasma membrane-targeted Ras in vivo unless a receptormediated translocation event occurs.
In summary, the data described above highlight, for the first time, a real biochemical distinction between the two putative IP 4 receptors, GAP1 IP4BP and GAP1 m . Of particular interest is the observation that plasma membrane targeting of GAP1 IP4BP is mediated by the PH domain through a motif that constitutes the IP 4 -binding site, suggesting that the localisation and function of GAP1 IP4BP might be regulated by the competition between phospholipid binding and IP 4 binding. The perinuclear localisation of GAP1 m has not been observed before and is likely to have important physiological consequences for the action of IP 4 .
Materials and methods

Materials
[ 32 P]IP 4 was prepared as previously described [14] . Chemicals were from Sigma unless otherwise stated, and all tissue culture media and reagents were from Gibco BRL. 
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Cloning of GAP1 m
Homologous primers (sense 5′-CAGGAGACTGGTGAAAAC-3′ and antisense 5′-TGGATTTTCCTTGCTCCC-3′) were used to amplify a 348 bp fragment by PCR from a human circulating-blood cDNA library (Stratagene No. 938202; oligo dT-primed and random-primed). After four rounds of screening three independent clones were isolated and excised in vivo into the pBK-CMV phagemid. One of these clones (PJC-5), thought likely to be full-length after restriction mapping, was sequenced on both strands using internal oligonucleotide primers on an Applied Biosystems automated DNA sequencer. The predicted open reading frame of 2547 bp encoded a 849 amino-acid protein with a predicted molecular mass of 96,500 Da.
Cloning and mutagenesis procedures
The various constructs used in this study were produced by the Expand TM High Fidelity PCR system (Boehringer) with primers designed to amplify the required fragment of cDNA. All constructs were sequenced prior to use. Vectors used for mammalian gene expression were pCI-neo (Promega) and pEGFP (Clontech), and GST constructs were made in pGEX vectors (Pharmacia). Site-directed mutagenesis of GAP1 IP4BP was performed with the Transformer TM kit (Clontech). More details of the cloning and mutagenesis are available as supplementary information linked to the internet version of the paper.
Preparation of GAP1 m (K45) and GAP1 IP4BP (H113) antiserum
The peptide SSSAKYGSKENPIVGKIS (which corresponds to the carboxyl terminus of rat brain GAP1 m [15] ) was conjugated to bovine purified protein derivative using sulfosuccinimidyl 4-[Nmaleimidomethyl]-cyclohexane-1-carboxylate (Sulfo-SMCC), mixed with Freund's adjuvant and injected into a rabbit. Anti-GAP1IP4BP antisera were isolated as previously described [1] .
Indirect immunofluorescence
Transfected cells were fixed in ice-cold PBS followed by immersion in 70% acetone/30% methanol for 10 min. Primary antibody was diluted to the desired concentration in PBS-Triton X-100 (0.1% v/v). Coverslips were soaked in PBS-Triton for 15 min prior to incubation with primary antibody for 1 h at 37°C. After the incubation, each coverslip was rinsed twice in PBS-Triton for 15 min with gentle agitation. The second antibody, anti-rabbit IgG (whole molecule) TRITC conjugate diluted in PBS-Triton (1:200), was added and incubated at 37°C for 1 hr. Coverslips were rinsed twice for 15 mins in PBS-Triton and mounted on glass microscope slides in 60% (v/v) glycerol/2.5% (w/v) 1,4-diazabicyclo-[2.2.2]octane. Immunofluorescence staining was visualised by a Leica TCS-NT confocal laser-scanning microscope equipped with a Kr/Ar laser. The confocal was attached to a Leica DM RBE upright epifluorescence microscope. GFP fluorescence in live cells was visualised using an identical system attached to an inverted microscope.
Expression of GST-∆C2GAP1 m and GST-∆C2GAP1 IP4BP constructs in Escherichia coli
E. coli strain BL-21 expressing GroES/L chaperonins was transformed with pGEX-∆C2GAP1m or pGEX-∆C2GAP1IP4BP. Each resultant GST fusion was isolated by incubation with glutathione sepharose 4B resin (Pharmacia Biotech) according to the manufacturer's instructions. IP 4 -binding assays were performed as previously described [14] .
Supplementary material
Further details on cloning, mutagenesis and cell culture are published with this paper on the internet.
